UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 588

Sortiert nach

Functional rare males in diploid parthenogenetic Artemia

Journal of evolutionary biology, 2013-09, Vol.26 (9), p.1934-1948

2013

Volltextzugriff (PDF)

Étude des onychomycoses en médecine de ville dans la région lyonnaise

Journal de mycologie médicale, 2011-06, Vol.21 (2), p.118-122

2011

Volltextzugriff (PDF)

Hematological parameters, liver integrity and growth of Nile tilapia fingerlings fed diets supplemented with propolis extract

Spanish journal of agricultural research : SJAR, 2021-01, Vol.19 (4), p.e0612

2021

Volltextzugriff (PDF)

Developing a new predictor of health expenditure: preliminary results from a primary healthcare setting

Public health (London), 2018-10, Vol.163, p.121-127

2018

Volltextzugriff (PDF)

Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study

ESMO open, 2024-06, Vol.9 (6), p.103485, Article 103485

2024

Volltextzugriff (PDF)

P20.14.B SYSTEMIC THERAPY FOR RECURRENT ADULT INTRACRANIAL AND SPINAL EPENDYMOMAS: A MONO-INSTITUTIONAL EXPERIENCE

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii130-ii130

2023

Volltextzugriff (PDF)

543P Bevacizumab and hydroxyurea treatment in grade 2 and 3 meningioma: A monocentric experience

Annals of oncology, 2023-10, Vol.34, p.S407-S407

2023

Volltextzugriff (PDF)

310P Bevacizumab in meningiomas: A monocentric experience

Annals of oncology, 2022-09, Vol.33, p.S678

2022

Volltextzugriff (PDF)

297P The genetic profile of primary and recurrent gliomas: A mono-institutional experience using next-generation sequencing

Annals of oncology, 2022-09, Vol.33, p.S674

2022

Volltextzugriff (PDF)

P18.05.A Bevacizumab in atypical and anaplastic meningiomas: the BEMEN study

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii95-ii95

2022

Volltextzugriff (PDF)

Optical response of alkali metal atoms confined in nanoporous glass

Quantum electronics (Woodbury, N.Y.), 2014-01, Vol.44 (3), p.263-268

2014

Volltextzugriff (PDF)

502MO Target therapy matched to genomic alterations in patients with recurrent IDH wildtype glioblastoma: A real-life cohort analysis from Veneto Institute of Oncology, Padua (Italy)

Annals of oncology, 2023-10, Vol.34, p.S393-S393

2023

Volltextzugriff (PDF)

289MO Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: A large mono institutional experience

Annals of oncology, 2022-09, Vol.33, p.S671

2022

Volltextzugriff (PDF)

P17.06.B TARGETED THERAPY MATCHED TO GENOMIC ALTERATIONS (BRAFV600E, NTRK, FGFR, ROS1, PIK3CA, PTEN) IN PATIENTS WITH RECURRENT IDH WILDTYPE GLIOBLASTOMA: A REAL-LIFE COHORT ANALYSIS FROM VENETO INSTITUTE OF ONCOLOGY, PADUA (ITALY)

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii117-ii118

2023

Volltextzugriff (PDF)

P02.02.A Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: a large mono institutional experience

Neuro-oncology (Charlottesville, Va.), 2022-09, Vol.24 (Supplement_2), p.ii29-ii29

2022

Volltextzugriff (PDF)

OS09.2.A REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2, EUDRA CT N° 2021-001604-15)

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii20-ii20

2023

Volltextzugriff (PDF)

Skin Testing Correlates Negatively with High-Activity ACP1 B/C Genotype

International archives of allergy and immunology, 2008, Vol.145 (1), p.48-53

2008

Volltextzugriff (PDF)

Onychomycosis in private practice in Lyon area, France

Journal de mycologie médicale, 2011-06, Vol.21 (2), p.118-122

2011

Volltextzugriff (PDF)

Gender differences in health expenditure determinants

European journal of public health, 2016-11, Vol.26 (suppl_1)

2016

Volltextzugriff (PDF)

Gender differences in health expenditure determinants: A follow-up study

Health care for women international, 2019-01, Vol.40 (1), p.33-46

2019

Volltextzugriff (PDF)

Evaluating a new immunoassay method for fecal occult blood test

European journal of public health, 2014-10, Vol.24 (suppl_2)

2014

Volltextzugriff (PDF)

Functional rare males in diploid parthenogenetic A rtemia

Journal of evolutionary biology, 2013-09, Vol.26 (9), p.1934-1948

2013

Volltextzugriff (PDF)

There are still differences in the diffusion of screening campaigns in Italy

European journal of public health, 2013-10, Vol.23 (suppl_1)

2013

Volltextzugriff (PDF)

Detection: Definition of New Model to Reveal Advanced Persistent Threat

Proceedings of the Future Technologies Conference (FTC) 2018, 2018, Vol.881, p.305-323

2018

Volltextzugriff (PDF)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

Frontiers in immunology, 2018-03, Vol.9, p.543-543

2018

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(425)
Mit Volltextzugriff
(465)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(248)
Life Sciences & Biomedicine
(205)
Humans
(150)
Male
(134)
Animals
(122)
Female
(107)
Biological And Medical Sciences
(96)
Rats
(81)
Adult
(55)
Middle Aged
(55)
Fundamental And Applied Biological Sciences. Psychology
(51)
Neurosciences & Neurology
(50)
Neurosciences
(49)
Psoriasis
(49)
Medical Sciences
(48)
Aged
(36)
Rats, Sprague-Dawley
(36)
Pharmacology & Pharmacy
(34)
Physical Sciences
(31)
Life Sciences
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Functional rare males in diploid parthenogenetic Artemia

Étude des onychomycoses en médecine de ville dans la région lyonnaise

Hematological parameters, liver integrity and growth of Nile tilapia fingerlings fed diets supplemented with propolis extract

Developing a new predictor of health expenditure: preliminary results from a primary healthcare setting

Dissecting the prognostic signature of patients with astrocytoma isocitrate dehydrogenase-mutant grade 4: a large multicenter, retrospective study

P20.14.B SYSTEMIC THERAPY FOR RECURRENT ADULT INTRACRANIAL AND SPINAL EPENDYMOMAS: A MONO-INSTITUTIONAL EXPERIENCE

543P Bevacizumab and hydroxyurea treatment in grade 2 and 3 meningioma: A monocentric experience

310P Bevacizumab in meningiomas: A monocentric experience

297P The genetic profile of primary and recurrent gliomas: A mono-institutional experience using next-generation sequencing

P18.05.A Bevacizumab in atypical and anaplastic meningiomas: the BEMEN study

Optical response of alkali metal atoms confined in nanoporous glass

502MO Target therapy matched to genomic alterations in patients with recurrent IDH wildtype glioblastoma: A real-life cohort analysis from Veneto Institute of Oncology, Padua (Italy)

289MO Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: A large mono institutional experience

P17.06.B TARGETED THERAPY MATCHED TO GENOMIC ALTERATIONS (BRAFV600E, NTRK, FGFR, ROS1, PIK3CA, PTEN) IN PATIENTS WITH RECURRENT IDH WILDTYPE GLIOBLASTOMA: A REAL-LIFE COHORT ANALYSIS FROM VENETO INSTITUTE OF ONCOLOGY, PADUA (ITALY)

P02.02.A Next-generation sequencing (NGS) for identifying actionable molecular alterations in newly diagnosed and recurrent IDHwt-glioblastoma (GBM) patients: a large mono institutional experience

OS09.2.A REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2, EUDRA CT N° 2021-001604-15)

Skin Testing Correlates Negatively with High-Activity ACP1 B/C Genotype

Onychomycosis in private practice in Lyon area, France

Gender differences in health expenditure determinants

Gender differences in health expenditure determinants: A follow-up study

Evaluating a new immunoassay method for fecal occult blood test

Functional rare males in diploid parthenogenetic A rtemia

There are still differences in the diffusion of screening campaigns in Italy

Detection: Definition of New Model to Reveal Advanced Persistent Threat

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry

Suchergebnisse filtern